<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Cactus <z:chebi fb="5" ids="18154">polysaccharides</z:chebi> (CP), some of the active components in Opuntia dillenii Haw have been reported to display neuroprotective effects in rat brain slices </plain></SENT>
<SENT sid="1" pm="."><plain>In the present study, we investigated the neuroprotective properties of CP and their potential mechanisms on <z:e sem="disease" ids="C0007786" disease_type="Disease or Syndrome" abbrv="">brain ischemia</z:e>-reperfusion injury in rats, and on <z:mp ids='MP_0003674'>oxidative stress</z:mp>-induced damage in PC12 cells </plain></SENT>
<SENT sid="2" pm="."><plain>Male Sprague-Dawley rats with <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> following middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> and reperfusion were investigated </plain></SENT>
<SENT sid="3" pm="."><plain>CP (200 mg/kg) significantly decreased the neurological deficit score, reduced <z:mpath ids='MPATH_124'>infarct</z:mpath> volume, decreased <z:hpo ids='HP_0002529'>neuronal loss</z:hpo> in cerebral cortex, and remarkably reduced the protein synthesis of inducible nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> synthase which were induced by <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> and reperfusion </plain></SENT>
<SENT sid="4" pm="."><plain>Otherwise, the protective effect of CP was confirmed in in vitro study </plain></SENT>
<SENT sid="5" pm="."><plain>CP protected PC12 cells against <z:chebi fb="17" ids="16240">hydrogen peroxide</z:chebi> (<z:chebi fb="0" ids="16240">H(2)O(2)</z:chebi>) insult </plain></SENT>
<SENT sid="6" pm="."><plain>Pretreatment with CP prior to <z:chebi fb="0" ids="16240">H(2)O(2)</z:chebi> exposure significantly elevated cell viability, reduced <z:chebi fb="0" ids="16240">H(2)O(2)</z:chebi>-induced <z:mpath ids='MPATH_3'>apoptosis</z:mpath>, and decreased both intracellular and total accumulation of reactive oxygen species (ROS) production </plain></SENT>
<SENT sid="7" pm="."><plain>Furthermore, CP also reversed the upregulation of Bax/Bcl-2 mRNA ratio, the downstream cascade following ROS </plain></SENT>
<SENT sid="8" pm="."><plain>These results suggest that CP may be a candidate compound for the treatment of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> and <z:mp ids='MP_0003674'>oxidative stress</z:mp>-induced <z:hpo ids='HP_0002180'>neurodegenerative disease</z:hpo> </plain></SENT>
</text></document>